MALIGNANT SOLID NEOPLASM
Clinical trials for MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early COVID-19 treatment trial for vulnerable cancer patients halted
Disease control TerminatedThis early-stage study tested whether two immune-stimulating drugs (rintatolimod and interferon) could help cancer patients fight off COVID-19 infections. The trial aimed to find safe doses and see if the treatment reduced the amount of virus in patients. It was designed for adul…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Race to tame deadly side effect of promising cancer drugs
Disease control TerminatedThis study aimed to find a better treatment for a serious lung inflammation that can occur as a side effect of certain cancer immunotherapies when standard steroid treatment fails. It tested two different drug combinations (infliximab or intravenous immunoglobulin) in cancer pati…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Program aims to ease family stress when a parent has advanced cancer
Symptom relief TerminatedThis study tested two educational programs designed to help parents with late-stage, non-curable cancer communicate with their children aged 5-17. The goal was to improve the parent-child relationship, boost the parent's confidence in discussing the illness, and reduce anxiety an…
Matched conditions: MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC